Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	31.98	75.91	57.51
Graham Fair Price	5.55	27.55	26.10
PEG	189.54	3.03	-1.05
Price/Book	6.36	7.57	7.12
Price/Cash Flow	-26.53	83.56	113.74
Prices/Earnings	1.34	25.24	24.91
Price/Sales	16.47	18.77	16.12
Price/FCF	-26.53	83.56	113.74
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	-2.82	0.51	0.53
Operating Margin	-14.60	0.23	0.27
ROA	9.25	0.03	0.03
ROE	0.07	0.07	4.95
ROIC	0.05	0.05	-14.56
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	-0.05	-0.06	15.07
Dividends QOQ	< 0.005	< 0.005	-9036.87
EBIT QOQ	< 0.005	-0.20	-3538.92
EPS QOQ	-0.24	0.08	-65.00
FCF QOQ	-0.24	0.49	108.50
Revenue QOQ	-0.02	-0.06	-195.58
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	63.45	64.63	1.87
Days Sales Outstanding (DSO)	26.59	27.29	2.65
Inventory Turnover	1.42	1.39	-1.83
Debt/Capitalization	0.41	0.39	-4.89
Quick Ratio	0.40	0.40	1.22
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	20.58	21.21	3.03
Cash	3.35	2.89	-13.55
Capex	-0.35	-0.34	2.55
Free Cash Flow	1.29	1.92	49.15
Revenue	9.09	8.56	-5.91
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	0.64	0.69	8.02
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	4.00	4.72	18.12
Naive Interpretation	Member

06 - Financial Health · Bad

Rating